5-[(1R)-1-[(1aR,4aR,7S,7aR,7bR)-1,1,7-trimethyl-4-methylidene-1a,2,3,4a,5,6,7a,7b-octahydrocyclopropa[h]azulen-7-yl]-3-methylbutyl]-2,4,6-trihydroxybenzene-1,3-dicarbaldehyde | 142628-53-3

• 物质功能分类: 天然产物 - 倍半萜
• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: 5-[(1R)-1-[(1aR,4aR,7S,7aR,7bR)-1,1,7-trimethyl-4-methylidene-1a,2,3,4a,5,6,7a,7b-octahydrocyclopropa[h]azulen-7-yl]-3-methylbutyl]-2,4,6-trihydroxybenzene-1,3-dicarbaldehyde
• 英文别名: 2,4,6-trihydroxy-5-[3-methyl-1-(1,1,7-trimethyl-4-methylidene-1a,2,3,4a,5,6,7a,7b-octahydrocyclopropa[h]azulen-7-yl)butyl]benzene-1,3-dicarbaldehyde
• CAS: 142628-53-3
• 化学式: C₂₈H₃₈O₅
• 分子量: 454.6
• InChiKey: IEWHEHWXBLPFER-UHFFFAOYSA-N

物化性质

• 沸点：
  509.6±50.0 °C(Predicted)
• 密度：
  1.20±0.1 g/cm3(Predicted)
• 溶解度：
  溶于氯仿、二氯甲烷、乙酸乙酯、DMSO、丙酮等。

计算性质

• 辛醇/水分配系数(LogP)：
  7.2
• 重原子数：
  33
• 可旋转键数：
  6
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.64
• 拓扑面积：
  94.8
• 氢给体数：
  3
• 氢受体数：
  5

文献信息

• EUCALYPTUS EXTRACT, METHOD OF PREPARATION AND THERAPEUTIC USES THEREOF
  申请人：Fiorini-Puybaret Christel

  公开号：US20090324754A1

  公开（公告）日：2009-12-31

  The present invention relates to the use of a Eucalyptus for preparation of a drug or a dietary supplement intended for treatment and/or prevention of affections or pathologies caused by neuromediator recapture disorder. The present invention also relates to a new enriched extract of Eucalyptus characterized in that it contains at least one compound having the formula (I) or any one of its diastereoisomers in which R1 forms a C═CH2 substituent with the carbon to which it is joined, a formula (II) substituent and R2 which represents an isobutyl, α-isobutyl or β-isobutyl substituent; and the method of preparation thereof.
• [EN] NEW EUCALYPTUS EXTRACT, METHOD OF PREPARATION AND THERAPEUTIC USES THEREOF<br/>[FR] NOUVEL EXTRAIT D'EUCALYPTUS, SON PROCEDE DE PREPARATION ET SES UTILISATIONS THERAPEUTIQUES
  申请人：PF MEDICAMENT

  公开号：WO2008017752A2

  公开（公告）日：2008-02-14

  [EN] The present invention relates to the use of a Eucalyptus extract for preparation of a drug or a dietary supplement intended for treatment and/or prevention of affections or pathologies caused by neuromediator recapture disorder. The present invention also relates to a new enriched extract of Eucalyptus characterized in that it contains at least one compound having the formula (I) or any one of its diastereoisomers in which Rl forms a C=CH2 substituent with the carbon to which it is joined, a formula (II) substituent and R2 which represents an isobutyl, a-isobutyl or ß-isobutyl substituent; and the method of preparation thereof.
  [FR] La présente invention concerne l'utilisation d'un extrait d'Eucalyptus pour la préparation d'un médicament ou d'un complément alimentaire destiné au traitement et/ou à la prévention des affections ou pathologies découlant d'un désordre de la recapture de neuromédiateurs. La présente invention concerne également un nouvel extrait enrichi d'Eucalyptus caractérisé en ce qu'il contient au moins 1 composé de formule (I) ou l'une quelconque de ses formes diastéréoisomères dans laquelle Rl forme avec le carbone auquel il est rattaché un groupement C=CH2, un groupement formule (II) et R2 re résente un rou ement isobut le,a-isobutyle ou ß-isobutyle; ainsi que son procédé de préparation.